Richard H. Holslag

Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.

Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland

Rhein Biotech NV developed and manufactured pharmaceutical drugs and vaccines. The company provided licenses to vaccines and biopharmaceutical products in the area of respiratory travel and hepatitis B/pediatric. Rhein Biotech was headquartered in Maastricht, the Netherlands.

Part of DSM-Firmenich AG, DSM Biomedical BV is a Dutch company that specializes in implantable drug delivery systems made of bioresorbable polymers. The private company is based in Geleen, the Netherlands. These systems release precise quantities of therapeutic agents gradually over time. DSM Biomedical materials and technologies are used in orthopedic applications, including spine, trauma, and sports medicine. White. The company was founded by Kathleen A.